Announced
Completed
Synopsis
Medtronic, a medical technology company, completed the acquisition of Intersect ENT, a medical technology company, for $1.1bn. "This acquisition directly aligns with our commitment to delivering continuous innovation that helps ENT patients. Intersect ENT's sinus implants are clinically proven to offer relief and healing to patients suffering from chronic rhinosinusitis. Combining this innovative technology with our established global presence and sales infrastructure will allow us to broaden our capabilities while expanding access to these valuable therapies," Vince Racano, Intersect ENT President.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.